Related Experiment Video
Updated: Apr 15, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
Retinoids Bias Integrin Expression and Function in Cutaneous T-Cell Lymphoma.
Lei Wang1, Sebastian S DeMarco1, JianMing Chen1
1Department of Biochemistry and Molecular Biology, The Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
Retinoids, used to treat Cutaneous T-cell lymphoma (CTCL), increase integrin β7 expression in malignant T-cells before inducing apoptosis. This mechanism may explain their therapeutic effectiveness in CTCL treatment.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Cutaneous T-cell lymphoma (CTCL) involves malignant T-cells in the skin.
- Retinoids are established therapies for CTCL, primarily acting by inducing growth arrest and apoptosis.
- The natural role of retinoids involves imprinting gut-homing properties via integrin α4β7 expression in T-cells.
Purpose of the Study:
- To investigate the relationship between the natural role of retinoids in T-cell biology and their therapeutic effectiveness in CTCL.
- To explore the early cellular changes induced by retinoids in CTCL.
Main Methods:
- Investigated the effect of retinoids on integrin β7 expression and function in CTCL cell lines.
- Examined the impact of 1,25-dihydroxyvitamin D3 on retinoid-induced CTCL cell adhesion.
- Analyzed the role of RAR and RXR nuclear receptors in retinoid-induced integrin-dependent adhesion changes.
Main Results:
- Retinoids, including Bexarotene, selectively increase integrin β7 expression and function in CTCL cells.
- This increase precedes retinoid-induced growth arrest and apoptosis.
- Retinoid-induced augmentation of CTCL cell adhesion was inhibited by 1,25-dihydroxyvitamin D3.
- Integrin-dependent adhesion changes were mediated by synergistic activation of RAR and RXR nuclear receptors.
Conclusions:
- Retinoids may sensitize CTCL cells to apoptosis by initially increasing integrin β7 expression and function.
- Understanding these early retinoid effects provides insights into CTCL pathogenesis and therapy.
- Vitamin D3 derivatives may modulate retinoid therapy by affecting immune cell homing properties.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

